Literature DB >> 12069978

Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori.

M M Gerrits1, D Schuijffel, A A van Zwet, E J Kuipers, C M J E Vandenbroucke-Grauls, J G Kusters.   

Abstract

Most Helicobacter pylori strains are susceptible to amoxicillin, an important component of combination therapies for H. pylori eradication. The isolation and initial characterization of the first reported stable amoxicillin-resistant clinical H. pylori isolate (the Hardenberg strain) have been published previously, but the underlying resistance mechanism was not described. Here we present evidence that the beta-lactam resistance of the Hardenberg strain results from a single amino acid substitution in HP0597, a penicillin-binding protein 1A (PBP1A) homolog of Escherichia coli. Replacement of the wild-type HP0597 (pbp1A) gene of the amoxicillin-sensitive (Amx(s)) H. pylori strain 1061 by the Hardenberg pbp1A gene resulted in a 100-fold increase in the MIC of amoxicillin. Sequence analysis of pbp1A of the Hardenberg strain, the Amx(s) H. pylori strain 1061, and four amoxicillin-resistant (Amx(r)) 1061 transformants revealed a few amino acid substitutions, of which only a single Ser(414)-->Arg substitution was involved in amoxicillin resistance. Although we cannot exclude that mutations in other genes are required for high-level amoxicillin resistance of the Hardenberg strain, this amino acid substitution in PBP1A resulted in an increased MIC of amoxicillin that was almost identical to that for the original Hardenberg strain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069978      PMCID: PMC127293          DOI: 10.1128/AAC.46.7.2229-2233.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  The cysteine-rich protein A from Helicobacter pylori is a beta-lactamase.

Authors:  P R Mittl; L Lüthy; P Hunziker; M G Grütter
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

2.  Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.

Authors:  M S Osato; R Reddy; S G Reddy; R L Penland; D Y Graham
Journal:  Int J Antimicrob Agents       Date:  2001-01       Impact factor: 5.283

4.  Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori.

Authors:  A G Harris; S L Hazell; A G Netting
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

Review 5.  Penicillin-binding proteins of gram-negative bacteria.

Authors:  B G Spratt; K D Cromie
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.

Authors:  R Paul; S Postius; K Melchers; K P Schäfer
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

7.  Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.

Authors:  H Wu; X D Shi; H T Wang; J X Liu
Journal:  J Antimicrob Chemother       Date:  2000-07       Impact factor: 5.790

8.  Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

9.  Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori.

Authors:  M P Dore; D Y Graham; A R Sepulveda
Journal:  Helicobacter       Date:  1999-09       Impact factor: 5.753

10.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

View more
  29 in total

Review 1.  Eradication of Helicobacter pylori: a clinical update.

Authors:  Marco Romano; Antonio Cuomo
Journal:  MedGenMed       Date:  2004-02-17

Review 2.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh.

Authors:  Shamsun Nahar; Asish K Mukhopadhyay; Rasel Khan; Mian Mashhud Ahmad; Simanti Datta; Santanu Chattopadhyay; Swapan Chandra Dhar; Shafiqul Alam Sarker; Lars Engstrand; Douglas E Berg; G Balakrish Nair; Motiur Rahman
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori.

Authors:  Edgie-Mark A Co; Neal L Schiller
Journal:  Antimicrob Agents Chemother       Date:  2006-09-25       Impact factor: 5.191

5.  Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing.

Authors:  Tran Thanh Binh; Rumiko Suzuki; Tran Thi Huyen Trang; Dong Hyeon Kwon; Yoshio Yamaoka
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

6.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

7.  High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.

Authors:  Maribel Rodríguez-Torres; Rosa Salgado-Mercado; Carlos F Ríos-Bedoya; Edgardo Aponte-Rivera; Acisclo M Marxuach-Cuétara; José F Rodríguez-Orengo; Alberto Fernández-Carbia
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 8.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.

Authors:  Francis Mégraud
Journal:  Gut Microbes       Date:  2013-08-05

10.  Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.

Authors:  Ju Yup Lee; Nayoung Kim; Min Soo Kim; Yoon Jin Choi; Jung Won Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  Dig Dis Sci       Date:  2014-03-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.